Triple
T22457853
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH CTD |
E555159
|
entity |
| Predicate | alsoKnownAs |
P39
|
FINISHED |
| Object | Common Technical Document for the Registration of Pharmaceuticals for Human Use |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Common Technical Document for the Registration of Pharmaceuticals for Human Use | Statement: [ICH CTD, alsoKnownAs, Common Technical Document for the Registration of Pharmaceuticals for Human Use]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Common Technical Document for the Registration of Pharmaceuticals for Human Use Context triple: [ICH CTD, alsoKnownAs, Common Technical Document for the Registration of Pharmaceuticals for Human Use]
-
A.
Community code for medicinal products for human use
The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
-
B.
Certificates of Suitability to the monographs of the European Pharmacopoeia
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
C.
ICH Q11 Development and Manufacture of Drug Substances
ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
-
D.
Commentar zur Pharmacopoea Germanica
Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
-
E.
Community register of orphan medicinal products
The Community register of orphan medicinal products is the official European Union list of medicines designated for the diagnosis, prevention, or treatment of rare diseases, maintained under the EU’s orphan drug framework.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Common Technical Document for the Registration of Pharmaceuticals for Human Use Target entity description: The Common Technical Document for the Registration of Pharmaceuticals for Human Use is an internationally harmonized format developed by the International Council for Harmonisation (ICH) for organizing and submitting data to regulatory authorities in support of new drug applications.
-
A.
Community code for medicinal products for human use
The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
-
B.
Certificates of Suitability to the monographs of the European Pharmacopoeia
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
C.
ICH Q11 Development and Manufacture of Drug Substances
ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
-
D.
Commentar zur Pharmacopoea Germanica
Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
-
E.
Community register of orphan medicinal products
The Community register of orphan medicinal products is the official European Union list of medicines designated for the diagnosis, prevention, or treatment of rare diseases, maintained under the EU’s orphan drug framework.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7d00208190955a70e2c22d25a4 |
completed | April 29, 2026, 1:14 a.m. |
Created at: April 16, 2026, 8:48 p.m.